The connection between Israeli design reform and lively Israeli mobile market

Co-published by Adv. Yehuda Neubauer, Partner, Ehrlich, Neubauer & Melzer of Ehrlich Group and Intellectual Asset Magazine(IAM) According to the Israel Patent Office’s (ILPO) annual reports, there has been a...

The IP Challenge in Patents For Repurposed Drugs and DRPx products

By: Dr. Hadassa Waterman, Head of the Biotech Department, Ehrlich & Fenster of Ehrlich Group Drug repurposing has been around for centuries. However, a recent report shows that in the...